Stockreport

BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight

Autolus Therapeutics plc - American Depositary Shares  (AUTL) 
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am Check Earnings Report
US:NASDAQ Investor Relations: autolus.com/investor-relations
PDF BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hem [Read more]